<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[HealthTechX360 - Medium]]></title>
        <description><![CDATA[Home of all news, insights and more, created by HealthTechX and other leading experts working in healthcare transformation. - Medium]]></description>
        <link>https://medium.com/healthtechx360?source=rss----51fbe69cfce1---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>HealthTechX360 - Medium</title>
            <link>https://medium.com/healthtechx360?source=rss----51fbe69cfce1---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 07:09:46 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/healthtechx360" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[HealthTechX Hall of Fame: how Lindus Health is re-imagining Clinical Research]]></title>
            <link>https://medium.com/healthtechx360/healthtechx-hall-of-fame-how-lindus-health-is-re-imagining-clinical-research-5aaabcbbafa7?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/5aaabcbbafa7</guid>
            <category><![CDATA[clinical-research]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[awards]]></category>
            <dc:creator><![CDATA[Andreea Bucescu]]></dc:creator>
            <pubDate>Wed, 03 Sep 2025 08:08:04 GMT</pubDate>
            <atom:updated>2025-09-03T08:08:04.294Z</atom:updated>
            <content:encoded><![CDATA[<h4>As we gear up for <a href="https://impactx2050.com/healthtechx">HealthTechX 2025</a> and the <a href="https://impactx2050.com/healthtechx/awards-2025">HealthTechX Awards</a>, find out how one of last year’s brilliant finalists is rebuilding the broken CRO model and expanding access to clinical research.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*nbYR_x4DeCb3TcjRwb975g.png" /></figure><p>In this Hall of Fame feature, we check in with Meri Beckwith, Co-CEO of Lindus Health — the self-described ‘Anti-CRO’ fixing the misaligned incentives and outdated infrastructure that have kept clinical research back for decades.</p><p>From running complex rare-disease studies for hard-to-reach patients, to building cutting-edge AI and data platforms recognised by regulators like the FDA, Lindus Health is proving that clinical trials can be <strong>faster, more accessible and more reliable</strong>.</p><p>Their approach — combining virtual sites, remote monitoring and advanced data harmonisation — is helping underserved patients participate, improving recruitment and setting new industry standards. And the industry is taking notice, as attested to by partnerships with Oxford University, CDISC and ARIA.</p><p>Dive in to our exclusive interview with Meri, and don’t forget — applicants to this year’s <a href="https://impactx2050.com/healthtechx/awards-2025">awards</a> receive a 50% discount to the HealthTechX 2025 Summit!</p><p><strong>Tell us about your business in short. Can you share a specific success story or case study that demonstrates the real-world impact of your innovation?</strong></p><p>Lindus Health is the Anti-CRO. We have taken the broken Contract Research Organisation (CRO) business model that has been the standard to run clinical trials for the last several decades, and created a new infrastructure that aligns incentives, leverages the best of technology and delivers better, faster clinical trials.</p><p>A recent example of our innovative techniques that comes to mind is a <a href="https://www.lindushealth.com/news/lindus-health-and-tiefenbacher-group-launching-clinical-trial-to-advance-me-cfs-research-and-treatment">drug study for a rare disorder called ME/CFS</a>. The study is quite complex with lots of different labs and screening assessments needed, all in a very tough-to-reach population that suffers from extreme fatigue and is rare to begin with.</p><p>We’re leveraging a combination of our in house eClinical Platform (Citrus™), virtual site, mobile logistics and remote monitor devices for sleep and hand grip testing. This has made the study far more accessible to patients in an extremely challenging population.</p><p><strong>Tell us about your last 12 months. What have you found most exciting, and most challenging?</strong></p><p>I think the most exciting thing is seeing how far we are advancing our internal technology to run better quality clinical trials.</p><p>Our AI and data management advances have been featured<a href="https://www.nature.com/articles/s41598-023-27416-7"> in Nature</a>, we’ve built landmark partnerships with CDISC (who collaborate with the FDA) to set data standards and receiving a <a href="https://www.lindushealth.com/news/lindus-health-awarded-funding-from-aria-to-build-safe-and-reliable-ai-for-clinical-trial-design">recent award from ARIA to build safer, more reliable clinical trial AI</a>. We continue to advance our eClinical platform Citrus™ setting the bar higher for data management and trial operations.</p><p>In terms of the most challenging aspects, I think this kind of goes hand-in-hand with the most exciting components. Interestingly enough, despite regulatory encouragement of better data practices through technology, our industry is very much stuck in the past. It takes a lot of work to bring on board stakeholders across the industry to make progress in adoption of better quality, more modern data practices. However, we see very encouraging signs from regulators, like the FDA, giving the industry the push they need to continually set the bar higher for adoption.</p><p><strong>What about the next 12 months? What excites you, and what keeps you up at night?</strong></p><p>Similar to the above I think there will be more industry harmonisation on data standards. We hope to continue pushing our work with CDISC and FDA to help align the industry towards a much clearer, higher quality path in this regard.</p><p>Keeps me up at night? There has been a lot of chatter in the industry around shifting funding within biotech borne out of many market dynamics driven by news with FDA, grants, therapeutic area focuses, funding environment, etc. The key for us is to keep up to date with the shape of industry demand and to use our adaptability to our advantage to meet those demands.</p><p><strong>How optimistic are you feeling about your space and its potential to have real impact? What trends are you expecting to see play out this year?</strong></p><p>The trends we’re most excited about include the convergence of AI and clinical operations — not just as a buzzword, but as genuine operational tools that automate monitoring, enable instant biostatistics and optimise study design.</p><p>We’re also seeing regulators like the FDA pushing the industry toward modernisation and better data practices, which validates our approach. The shift toward patient-centric, decentralised trial models is accelerating, making participation more accessible to diverse populations who’ve historically been underrepresented in clinical research.</p><p><strong>What topic or trend has flown under the radar in your opinion? What should we be talking about more?</strong></p><p>The misalignment of incentives in the traditional CRO model is a critical issue that doesn’t get enough attention. Most CROs operate on change-order business models where delays and complications actually increase their revenue. This creates a perverse incentive structure that’s fundamentally at odds with sponsors’ needs for speed and efficiency.</p><p>We should also be talking more about the accessibility crisis in clinical trials. Many trials still require participants to travel to physical sites multiple times, creating barriers for those with mobility issues, caregiving responsibilities or limited resources. Our work with ME/CFS patients — who suffer from extreme fatigue — demonstrates how virtual and hybrid models can dramatically expand access to underserved populations. The industry needs to recognise that patient accessibility isn’t just an ethical imperative; it’s essential for recruitment success and data quality.</p><p><strong>What impact did HealthTechX and the awards nominations have on your business? Have there been any unexpected opportunities, conversations etc. as a result?</strong></p><p>HealthTechX and winning last year’s award helped raise our profile among potential customers and partners. We actually met one of our largest customers at the event itself!</p><p>The exposure has particularly helped us connect with other companies tackling similar challenges in adjacent spaces — from digital therapeutics companies needing clinical validation to pharma companies exploring novel trial designs. These connections have led to strategic partnerships that strengthen our ability to deliver comprehensive solutions. The validation from being recognised alongside other transformative companies has also been instrumental in our recent funding discussions and helped establish our credibility as we expand into new therapeutic areas.</p><p><strong>How has regulation or government policy affected your work over the past year? What changes would you like to see?</strong></p><p>Regulatory bodies, particularly the FDA, have been increasingly supportive of modernisation in clinical trials, which has been encouraging for our tech-first approach. The push for better data standards and quality has validated our investments in AI and our eClinical platform. Our recent partnerships with CDISC for setting data standards and our ARIA award for building safer clinical trial AI demonstrate how we’re working alongside regulators to elevate industry practices.</p><p>However, we’d like to see more harmonisation of regulations across different regions to facilitate global trials. The current patchwork of requirements adds unnecessary complexity and cost. We’d also advocate for clearer guidance on AI use in clinical trials — while regulators are generally supportive, more specific frameworks would help accelerate adoption of these transformative technologies across the industry.</p><p><strong>Collaboration is key in HealthTech — what partnerships have been most valuable to you, and what kinds of collaborations are you looking for?</strong></p><p>Our partnerships with data standards organisations like CDISC have been invaluable in ensuring our technology aligns with regulatory expectations while pushing the boundaries of what’s possible.</p><p>Our collaboration with Oxford University on research into clinical trial participation across demographic groups exemplifies how academic partnerships can translate insights into actionable improvements.</p><p>We’re actively seeking collaborations with patient advocacy groups, particularly for rare diseases where recruitment is challenging. We’re also interested in partnerships with health systems and primary care networks that can help us expand our EHR screening capabilities beyond our current 45 million records. Technology partnerships that enhance our AI capabilities and remote monitoring solutions are also a priority as we continue to build out our platform’s capabilities.</p><p><strong>AI and automation are shaping healthcare in new ways — how do you see them impacting your area of expertise?</strong></p><p>AI is fundamentally transforming how we approach every aspect of clinical trials. Our Citrus™ platform leverages AI for automated central monitoring, catching data anomalies in real-time that human monitors might miss for weeks. We’re using it to optimise study protocols before trials begin, predicting potential bottlenecks and suggesting design improvements based on historical data.</p><p>The future impact will be even more profound. We envision AI enabling truly adaptive trials that can modify protocols in real-time based on emerging data, dramatically reducing the time and cost of drug development.</p><p>Natural language processing is already helping us screen EHRs more efficiently for patient recruitment. However, the key is responsible implementation — which is why we’re working with ARIA on building safer, more reliable clinical trial AI that maintains data integrity while accelerating timelines.</p><p><strong>What would you say to a new investor looking to invest into HealthTech?</strong></p><p>Look for companies solving real operational bottlenecks, not just adding digital layers to broken processes. The HealthTech space is full of point solutions that address symptoms rather than root causes. The clinical trial landscape is ripe for disruption, but it requires companies willing to tackle the entire value chain, not just optimise individual components.</p><p>Focus on business models that align incentives correctly. Also, pay attention to companies with strong regulatory relationships and data advantages — these create defensible moats in a heavily regulated industry. The winners will be those who can demonstrate real-world impact with concrete metrics: faster recruitment, better retention, higher quality data, and ultimately, getting treatments to patients sooner.</p><p><strong>And finally — who would you nominate for a HealthTechX Award? Who is the company to watch?</strong></p><p>While we’re excited about many innovative companies in the space, we’d highlight those tackling systemic healthcare challenges with comprehensive solutions rather than point fixes. Companies like Dash Bio who are reinventing what is possible in pre-clincial research, or SAVA Health who have developed an innovative new wearable continuous biomarker sensor with many applications beyond just blood glucose.</p><p><em>Find out more about the HealthTechX Awards and apply </em><a href="https://impactx2050.com/healthtechx/awards-2025"><em>here</em></a><em>.</em></p><figure><a href="https://impactx2050.com/healthtechx/awards-2025"><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*7NBwxppZnWokCJ9UcCb0Ug.png" /></a><figcaption>HealthTechX Awards</figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5aaabcbbafa7" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/healthtechx-hall-of-fame-how-lindus-health-is-re-imagining-clinical-research-5aaabcbbafa7">HealthTechX Hall of Fame: how Lindus Health is re-imagining Clinical Research</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[HealthTechX Hall of Fame: how SiSU delivered 1m+ health-checks]]></title>
            <link>https://medium.com/healthtechx360/healthtechx-hall-of-fame-how-sisu-delivered-5m-health-checks-1b590737f160?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/1b590737f160</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[preventative-health]]></category>
            <category><![CDATA[awards]]></category>
            <category><![CDATA[healthtech]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Wed, 27 Aug 2025 11:31:39 GMT</pubDate>
            <atom:updated>2025-09-01T08:55:41.555Z</atom:updated>
            <content:encoded><![CDATA[<h4>As we gear up for <a href="https://impactx2050.com/healthtechx">HealthTechX 2025</a> and the <a href="https://impactx2050.com/healthtechx/awards-2025">HealthTechX Awards</a>, find out how one of last year’s brilliant finalists is shaping the future of preventative health</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9afh1Hq1nq_OD5f-xVH9IA.png" /></figure><p>In this Hall of Fame feature, we catch up with SiSU Health and CEO Samantha Fay on how they’ve delivered more than 1 million health-checks, scaled at record pace and proven that community-based, personalised prevention data is no longer the future, but delivering impact today.</p><p>From community rollouts to corporate health programs, SiSU is re-writing the playbook on health outside traditional provision — and investors, policymakers and employers are taking notice.</p><p><strong>Tell us about your business in short.</strong></p><p>SiSU Health is a digital health business focused on prevention. Our self- service Health Stations and digital tools deliver accessible in-community screening and triage solutions that support population health, empower individuals and help reduce health inequalities.</p><p><strong>Can you share a speciﬁc success story or case study that demonstrates the real-world impact of your innovation?</strong></p><p>Our platform generates real-time, accurate population health data so we see the real-world impact of all of our solutions. Whether in places such as Southwark and Luton, where local authorities are using our platform to reach underserved communities with preventative health checks and earlier risk, or with employers such as JLR and the AA, using our platform to support employee health and wellbeing, delivering both health improvements and the measurable economic beneﬁts.</p><p><strong>Tell us about your last 12 months. What have you found most exciting, and most challenging?</strong></p><p>It’s been a year of exceptional growth. We surpassed 1 million self-service health checks and expanded our reach through new delivery channels — launching a digital NHS Health Check, a multi-national employer solution in 17 languages and deepening our presence in communities across the UK.</p><p>Our biggest excitement? This year, we saw community and employee health come together through the NHS Workforce Cardiovascular Health Check Programme, where SiSU Health delivered approximately 30% of the national NHS Health Check target for this initiative!</p><p>Our biggest challenge? Keeping up with demand and ensuring we continue to deliver measurable impact as we grow.</p><p><strong>What about the next 12 months? What excites you, and what keeps you up at night?</strong></p><p>We’re excited about building on the momentum to deliver prevention at scale — support more individuals to improve their health, accelerating our roadmap, embedding in more workplaces, community health pathways, and expanding partnerships. Plus our growth in Europe!</p><p>What keeps us up at night? Unlocking more pathways and seamless integrations with Partner and NHS systems, so we can further grow our impact and improve the User journey.</p><p><strong>How optimistic are you feeling about your space and its potential to have real impact? What trends are you expecting to see play out this year?</strong></p><p>We’re extremely optimistic. Prevention and early detection have never been more urgent and were strong themes in the new NHS long-term plan. Digital tools like ours are increasingly being recognised as critical infrastructure for population health.</p><p>This year, we expect to see:</p><p>· More investment in community-based screening</p><p>· Growth in digital NHS Health Check delivery</p><p>· Increased demand for biometric health data to support personalised care</p><p><strong>What topic or trend has ﬂown under the radar in your opinion? What should we be talking about more?</strong></p><p>The real power of in-community solutions (outside of the GP surgery) and prevention data as a strategic asset - not just for health outcomes, but for wider social and economic planning.</p><p>We do need to be cautious though. There’s been a strong focus on apps and at home tools, but many face challenges with low engagement and rely on self-reported data which is often inaccurate.</p><p><strong>What impact did HealthTechX and the awards nominations have on your business? Have there been any unexpected opportunities or conversations as a result?</strong></p><p>HealthTechX helped raise our visibility with key stakeholders and kick-start valuable new conversations.</p><p><strong>How has regulation or government policy affected your work over the past year? What changes would you like to see?</strong></p><p>The newly published NHS Long Term Plan is a positive step - it places prevention, health equity and digital innovation at the forefront. We’d like to see this direction backed by clearer plans and frameworks, to help proven solutions like ours scale faster.</p><p><strong>Collaboration is key in HealthTech - what partnerships have been most valuable to you, and what kinds of collaborations are you looking for?</strong></p><p>Our most valuable partnerships to date have been with local authorities, NHS, and corporates committed to improving health. These collaborations have allowed us to embed in communities and workplaces, reaching people where they are and proving impact.</p><p>Looking ahead, we’re keen to partner with more of these organisations, but also those that can help scale our impact further. That includes pharmaceutical and life sciences companies exploring real-world prevention data, and academic and research institutions looking at population health insights.</p><p>We believe collaboration is key to building an intelligent, connected prevention eco-system - and we’re ready to work with others who share that ambition.</p><p><strong>AI and automation are shaping healthcare in new ways - how do you see them impacting your area of expertise?</strong></p><p>AI will be a gamechanger for prevention - especially in risk stratiﬁcation and personalised signposting, but it must be grounded in high-quality input data.</p><p><strong>What would you say to a new investor looking to invest into HealthTech?</strong></p><p>Focus on companies that combine clinical integrity with commercial scalability. Prevention is ﬁnally getting the attention it deserves, and models that are rooted in real-world impact and strong partnerships - like SiSU Health - are best placed to grow sustainably.</p><p><strong>And ﬁnally – who would you nominate for a HealthTechX Award? Who is the company to watch?</strong></p><p>We’d nominate Genomics Ltd., a company at the forefront of genomic risk intelligence and preventative data science.</p><p><em>Find out more about the HealthTechX Awards and apply </em><a href="https://impactx2050.com/healthtechx/awards-2025"><em>here</em></a><em>.</em></p><figure><a href="https://impactx2050.com/healthtechx/awards-2025"><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*7NBwxppZnWokCJ9UcCb0Ug.png" /></a><figcaption>HealthTechX Awards</figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1b590737f160" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/healthtechx-hall-of-fame-how-sisu-delivered-5m-health-checks-1b590737f160">HealthTechX Hall of Fame: how SiSU delivered 1m+ health-checks</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthcare’s Freeserve Moment]]></title>
            <link>https://medium.com/healthtechx360/healthcares-freeserve-moment-feb30c5ce248?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/feb30c5ce248</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[patient-engagement]]></category>
            <category><![CDATA[nhs]]></category>
            <category><![CDATA[healthtech]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Tue, 19 Aug 2025 15:23:39 GMT</pubDate>
            <atom:updated>2025-08-19T15:40:27.856Z</atom:updated>
            <content:encoded><![CDATA[<h4>From home tests to AI care plans: why the NHS App could be the launchpad for healthcare’s next big leap.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6PJRtBDQDLuBny_4YWUOYw.png" /></figure><p>The launch of Freeserve in 1998 was a founding moment for Europe. People queued outside electronics shops to collect the free CD that gave them home internet access, made possible only after the UK opened up its telecoms network to the private sector. That regulatory shift created the conditions for an explosion of new online services and business models, which spread across Europe and transformed consumer life.</p><p>We may be witnessing a similar founding moment with the NHS App in England. Like Freeserve in the late 1990s, the NHS App has become an open gateway to a critical national infrastructure — this time, healthcare. England’s market is large enough to matter, larger than most in Europe, yet far more orderly than the USA’s. The NHS login provides identity verification that patients can complete from anywhere, and the App’s terms of service offer strong safeguards against exploitation. Crucially, it is open to new entrants in a way no other healthcare market in Europe currently is, potentially setting the stage for a wave of health innovation comparable to the internet boom that followed Freeserve.</p><p>From the beginning, the NHS App team focused on a narrow set of features: GPs’ record access, appointment booking and prescription renewal. For everything else it signalled a desire for a market. This is unusual — Scotland and Northern Ireland have no such market or desire. NHS Wales followed England’s footsteps by using the original source code of the NHS App. Denmark, Estonia, France, Hungary Italy, Spain, Sweden and Turkey each contracted with one software developer and locked out everyone else. This was a pattern which we saw in our book “Personal Health Records for Governments”. This was the pattern of national telecom monopolies of old.</p><p>England began the process with digital suppliers for GP buyers. Econsult and other online triage systems allowed GPs, and then ICS regions, to choose between different approaches to assessing a patient. AccuRx and others handled online consultations between patient and GP surgeries. Both Econsult and AccuRx received venture capital funding.</p><p>Expanding the market to hospitals increased the available budgets. Zesty and others allow appointment booking, handling the complexity and heterogeneity across different hospital departments. More venture capital funding flowed.</p><p>For us at Patients Know Best (PKB), it is a privilege to work with the newest generation of innovators. We show the patient their medical records in the NHS App. Our APIs allow anyone serving a patient to add to the medical record, which we show in the NHS App. And the innovators are expanding and redefining what is useful in the medical record.</p><p>PocDoc does cholesterol checks at home. Testcard does urine infection tests at home. MyHealthChecked does other blood tests at home and recently expanded to genetic tests. Holly Health teaches and tracks health habits. MyRenalCare provides automated kidney dialysis advice. All the data flowing in is medically coded so that today’s doctors’ medical record systems can consume it, and tomorrow’s AI systems can do things I cannot even imagine today. Crucially in this model, it’s the patient who has ownership of their PKB record, deciding who they share their data with and when.</p><p>The next generation of innovators is building on the NHS record of the patient, combining it with data from the patient’s phone to give automated care plans. Your smartphone is the best behaviour change tool in humanity’s history. Wouldn’t it be good if it supported good changes?</p><p>Other European governments have not yet picked this up from the UK. But they always do and they will. And we already see emerging markets seeing these benefits. That widens the market for investors, and hastens the innovation for consumers. It won’t happen as fast as the Freeserve revolution — this is healthcare after all — but it won’t be as slow as before. Sensors plus AI plus a market means a new era.</p><p>This is why the audience IBIS Capital is pulling together at <a href="https://impactx2050.com/healthtechx">HealthTechX</a> is so important and so timely. 2026 will be a great year for patients and it will be because of the innovators who attend HealthTechX 2025.</p><p>At <strong>HealthTechX Summit</strong> on <strong>5 November</strong>, we’ll explore how <strong>Consumer Health</strong> is becoming a reality in the NHS and beyond, why <strong>AI in healthcare</strong> is poised for its next leap, and how <strong>wearables</strong> and other connected devices are joining the dots in <strong>Value-Based Healthcare</strong>. We’ll also look at the opportunities and challenges of <strong>consumerisation in health</strong> — and what it means for access, innovation, and the shape of a two-tier system.</p><p>These are just some of the issues we’ll be tackling across a packed agenda. Join us at the prestigious <strong>Hurlingham Club in London</strong> on <strong>5 November — </strong>and meet the people defining healthcare’s next era.</p><p>👉 <a href="https://impactx2050.com/healthtechx/tickets-2025">Book here</a> — 50% off tickets until 14 Sept with code HTX25SUMMER50</p><figure><a href="https://impactx2050.com/healthtechx/tickets-2025"><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*aLvAvFpRlb4hyQtpMzEo3w.png" /></a></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=feb30c5ce248" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/healthcares-freeserve-moment-feb30c5ce248">Healthcare’s Freeserve Moment</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[HealthTechX Hall of Fame: How Dr Julian delivered 1m+ therapy sessions]]></title>
            <link>https://medium.com/healthtechx360/healthtechx-hall-of-fame-how-dr-julian-delivered-1m-therapy-sessions-6773e855a12c?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/6773e855a12c</guid>
            <category><![CDATA[therapy]]></category>
            <category><![CDATA[mental-health]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[healthtech]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Mon, 04 Aug 2025 10:37:42 GMT</pubDate>
            <atom:updated>2025-08-05T08:27:38.051Z</atom:updated>
            <content:encoded><![CDATA[<h4>As we gear up for <a href="https://impactx2050.com/healthtechx">HealthTechX 2025</a> and the <a href="https://impactx2050.com/healthtechx/awards-2025">HealthTechX Awards</a>, find out how one of last year’s brilliant HealthTechX Awards finalists is building an AI-powered ‘Therapist in Your Pocket’.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/700/1*BAOtv3T9dXTp36rn8gCVbw.png" /></figure><p>Mental health services are under strain. Demand is rising fast, and the cracks are starting to show — in primary care, workplaces and schools.</p><p>While many digital health players are still finding their footing after the post-COVID hangover, Dr Julian is quietly building something powerful: a Therapist in Your Pocket. We spoke to founder Dr Julian Nesbitt on what he’s been up to this year, what’s next for digital mental health and how the HealthTechX Awards supercharged his exposure.</p><p>To join Dr Julian and our other Hall of Famers, and get a 50% discount to our HealthTechX Summit, apply to the 2025 HealthTechX Awards <a href="https://impactx2050.com/healthtechx/awards-2025">here</a>👈</p><p><strong>Tell us about your business in short. Can you share a specific success story or case study that demonstrates the real-world impact of your innovation?</strong></p><p>Dr Julian is a digital mental health platform transforming how therapy is accessed, delivered, and scaled. We provide both high-quality clinical services and a licensed technology platform (SaaS) that enables other organisations to deliver care through our infrastructure.</p><p>Our platform has provided over 1 million sessions of discreet, rapid-access therapy, for example partnering with NHS Practitioner Health to help preserve the wellbeing of healthcare professionals during the most demanding times.</p><p><strong>Tell us about your last 12 months. What have you found most exciting, and most challenging?</strong></p><p>The most exciting milestone has been reaching profitability while expanding our SaaS model. We’ve successfully transitioned from being solely a service provider to becoming a trusted digital infrastructure partner for NHS trusts, charities, and third-sector organisations.</p><p>The biggest challenge has been navigating NHS funding volatility and structural changes in commissioning. We had to streamline operations, make tough staffing decisions, and rebuild from a leaner foundation — emerging stronger and more focused.</p><p><strong>What about the next 12 months? What excites you, and what keeps you up at night?</strong></p><p>We’re scaling into new verticals: neurodiversity (ADHD, autism), executive coaching, and international mental health infrastructure. What excites us is enabling culturally sensitive, flexible, and AI-supported care at a global scale — especially in underserved regions.</p><p>We’ve also now able to provide personalised resources by location for different population groups, enabling more targeted and accessible mental health support across regions. This is about to be launched in Scotland, where our platform will serve as a national front door for mental health services. The system offers individuals access to personalised dashboards, self-help tools, and tailored signposting — enabling population-level reach while meeting people where they are, even before clinical contact.</p><p>What keeps me up at night is the pace of change — balancing innovation with compliance, growth with sustainability, and human touch with automation.</p><p><strong>How optimistic are you feeling about your space and its potential to have real impact? What trends are you expecting to see play out this year?</strong></p><p>We’re incredibly optimistic. The mental health crisis is global, but so is the appetite for scalable, tech-enabled solutions. We expect that:</p><ol><li>NHS outsourcing to digital-first providers will accelerate.</li><li>Demand for neurodivergent-friendly tools will rise.</li><li>AI co-pilots for therapy (e.g. digital homework, self-help companions) will become standard</li></ol><p><strong>What topic or trend has flown under the radar in your opinion? What should we be talking about more?</strong></p><p>One under-discussed issue is the outdated infrastructure underpinning mental health delivery. Too often, systems are rigid, fragmented, and built around the needs of providers rather than patients.</p><p>We need modernised infrastructure that enables truly personalised, patient-centred care. That means flexible digital tools that adapt to individual needs, faster and smarter clinician matching, self-service booking, multilingual support, and intelligent triage that goes beyond tick-box questionnaires.</p><p>It’s not just about more therapy — it’s about better, more tailored therapy, delivered through a system that fits people’s lives. The technology exists. The challenge now is alignment, adoption, and integration.</p><p><strong>What impact did HealthTechX and the awards nominations have on your business?</strong></p><p>The HealthTechX recognition gave us valuable visibility and credibility at a critical moment. It led to meaningful conversations with investors and commissioners who might not have otherwise been aware of our progress. It also inspired the team and reminded us that even during tough market conditions, our impact is being noticed.</p><p><strong>What changes would you like to see to government policy and regulation?</strong></p><p>Regulatory complexity has increased — especially around digital therapeutics, Right to Choose, and workforce models. While patient safety is paramount, we need clearer pathways for digital-first providers to be accredited and reimbursed. We’d love to see streamlined CQC approvals for digital platforms and recognition of AI as an augmentation tool rather than a replacement.</p><p><strong>What partnerships have been most valuable to you, and what kinds of collaborations are you looking for?</strong></p><p>Our NHS partnerships — particularly with forward-thinking ICBs and trusts — have been vital. We’ve also built strong collaborations with corporate wellbeing providers and national charities.</p><p>We’re now looking to partner with:</p><ol><li>ADHD and autism clinics seeking digital tools or tech-enabled growth</li><li>Research institutions for AI/mental health RCTs</li><li>Global NGOs or governments looking for national infrastructure</li></ol><p><strong>AI and automation are shaping healthcare in new ways — how do you see them impacting your area of expertise?</strong></p><p>We’re building an AI-enhanced “therapist in your pocket” that supports clients between sessions — via intelligent homework, triage, and emotion tracking. AI will augment — not replace — human therapists, making care more personalised, continuous, and scalable.</p><p>It also helps match patients to the right clinician — improving outcomes and reducing dropouts. We see AI as a force for equity, helping those who wouldn’t otherwise engage with therapy.</p><p><strong>What would you say to a new investor looking to invest into HealthTech?</strong></p><p>This space is no longer early-stage — it’s critical infrastructure. Mental health demand is surging, and traditional systems can’t cope. Invest in companies with real-world traction, NHS credibility, and a platform that can flex across use cases.</p><p>Look for those that blend tech with empathy, clinical rigour with innovation. The winners will be those who can humanise the digital experience.</p><figure><a href="https://impactx2050.com/healthtechx"><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*YjrhEEjzlugImzapg3KlPw.png" /></a><figcaption><a href="https://impactx2050.com/healthtechx">Find out more about HealthTechX here</a></figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6773e855a12c" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/healthtechx-hall-of-fame-how-dr-julian-delivered-1m-therapy-sessions-6773e855a12c">HealthTechX Hall of Fame: How Dr Julian delivered 1m+ therapy sessions</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[From Prescription to Prevention — The Challenge of Lifestyle Change]]></title>
            <link>https://medium.com/healthtechx360/from-prescription-to-prevention-the-challenge-of-lifestyle-change-9988bba84414?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/9988bba84414</guid>
            <category><![CDATA[future-of-healthcare]]></category>
            <category><![CDATA[healthy-lifestyle]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[lifestyle-change]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Tue, 26 Mar 2024 09:02:38 GMT</pubDate>
            <atom:updated>2024-03-26T09:02:37.830Z</atom:updated>
            <content:encoded><![CDATA[<h3>From Prescription to Prevention — The Challenge of Lifestyle Change</h3><h4>Exploring the complexities of implementing lifestyle changes to address chronic conditions and how technology can be leveraged to support this endeavour.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xvR0YZvhASs90phmLpaHtA.jpeg" /><figcaption>From left: <strong>Professor Sneh Khemka</strong>, NED, Investor as moderator; <strong>Peter Ward</strong>, Co-Founder &amp; CEO at Humanity; <strong>Dr Jay Shah</strong>, Chief Medical Officer at Aktiia;<strong> Dr Samantha Field</strong>, co-chair of the Faculty of Public Health’s AI and Digital Health Special Interest Group and <strong>Dr Matthew Fenech</strong>, Co-Founder &amp; Chief Medical Officer at Una Health.</figcaption></figure><p>In the realm of healthcare, addressing chronic conditions often involves prescribing lifestyle changes. Yet, implementing and sustaining these changes pose significant challenges for individuals and healthcare systems alike. However, with advancements in technology, there is newfound hope for facilitating and supporting these elusive lifestyle changes. A recent panel session at the 2024 HealthTechX Summit brought together experts to explore how technology can be harnessed to help individuals lead healthier lives. Let’s delve into the key insights from this discussion.</p><p><strong>Defining the Landscape</strong>: The session began by emphasizing the profound impact of lifestyle on chronic disease. From obesity to hypertension, lifestyle choices play a defining role in health outcomes. However, addressing these behaviours goes beyond simply prescribing solutions — it requires understanding the individual’s motivations for change, a task deemed incredibly difficult yet crucial.</p><p><strong>Biomarkers and Aggregate Data</strong>: One approach discussed involved utilizing biomarkers and aggregate data to gain insights into patterns of aging and disease progression. By leveraging breakthroughs in science and technology, including generative AI, it was argued that lifestyle changes could be distributed at scale, positively impacting underserved populations.</p><p><strong>Challenging the Status Quo</strong>: The session challenged conventional healthcare models, advocating for a shift towards preventive care. Speakers highlighted the need for healthcare systems to step up their efforts in addressing chronic conditions, rather than focusing solely on episodic care.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*iWjnyFu0DaDyydOLxJkI0A.png" /><figcaption>HealthTechX 2024: Panellists discussing the challenges of lifestyle change.</figcaption></figure><p><strong>Rethinking Medication</strong>: While medications like GLP-1 offer benefits, the real solution lies in promoting lifestyle changes. It was emphasized that creating low-cost, scalable solutions to initiate this journey is essential, thereby reducing reliance on pharmaceutical interventions.</p><p><strong>Tackling Non-Compliance and Obesity</strong>: Non-compliance with lifestyle changes, particularly in combating obesity, was acknowledged as a significant hurdle. Policy interventions and structural changes were deemed integral to addressing these challenges effectively.</p><p><strong>The Role of Technology</strong>: Technology was heralded as a game-changer in facilitating sustainable behavioural changes. While current devices primarily focus on monitoring, there is a call for more primary solutions that support lifestyle modifications. Innovations in generative AI and synthetic data sets were highlighted as promising avenues for personalized prevention strategies.</p><p><strong>Empowering Population-Level Impact</strong>: As technology drives personalized prevention, it’s essential to consider its implications at a population level. While innovations hold immense promise, there’s a need to ensure equitable access to these solutions, thus mitigating entrenched health inequalities.</p><p>The session underscored the transformative potential of technology in bridging the gap from prescription to prevention. By harnessing the power of HealthTech, we can empower individuals and healthcare systems to facilitate and sustain lifestyle changes effectively. As we navigate this evolving landscape, it’s imperative to prioritize accessibility and equity, ensuring that all individuals, regardless of their background, can benefit from these innovations in the pursuit of healthier lives.</p><p><a href="https://impactx2050.com/healthtechx/pre-reg-2025"><strong><em>Pre-register here</em></strong></a><em> </em><strong><em>for a 50% discount on 2025 HealthTechX Summit tickets.</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9988bba84414" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/from-prescription-to-prevention-the-challenge-of-lifestyle-change-9988bba84414">From Prescription to Prevention — The Challenge of Lifestyle Change</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Balancing Efficacy and Access in HealthTech]]></title>
            <link>https://medium.com/healthtechx360/balancing-efficacy-and-access-in-healthtech-6cdc0671e4ff?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/6cdc0671e4ff</guid>
            <category><![CDATA[healthcare-efficiency]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[access-to-healthcare]]></category>
            <category><![CDATA[future-of-healthcare]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Fri, 22 Mar 2024 09:02:53 GMT</pubDate>
            <atom:updated>2024-03-22T09:02:52.909Z</atom:updated>
            <content:encoded><![CDATA[<h4>HealthTechX 2024: Exploring how technology can help healthcare systems create solutions for chronically ill patients which are both effective and widely accessible.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*QLZCnq4_eChC4uZnAmKQ5Q.jpeg" /><figcaption>The Efficacy vs. Access Axis: Dr Shubs Upadhyay, Director of Medical Quality at Ada Health (left) in conversation with Dr Vishaal Virani, Head of Health at YouTube UK &amp; Ireland at the 2024 HealthTechX Summit.</figcaption></figure><p>The interplay between delivering effective healthcare and ensuring broad accessibility, particularly for chronically ill patients, is a complex balance. At the recent HealthTechX Summit, Dr Vishaal Virani, Head of Health at YouTube UK &amp; Ireland joined Dr Shubs Upadhyay, Director of Medical Quality at Ada Health for an engaging fireside chat on leveraging technology to bridge the gap between efficacy and access in healthcare.</p><p>How can we deliver health messaging at scale while maintaining effectiveness at the individual level? Dr. Virani emphasized the importance of tailoring content on platforms like YouTube to specific audiences, ensuring that information is both accessible and credible. This includes labelling health authority videos to denote content from licensed professionals, thereby fostering trust among viewers.</p><p>However, amidst the wealth of online health information lies the risk of misinformation, which can have detrimental effects on patient outcomes. It was highlighted that high-quality information serves as a facilitator for informed conversations between patients and clinicians, ultimately enhancing continuity of care, particularly for chronic conditions.<br>The conversation touched upon the role of clinicians as advocates for online health content. By endorsing resources such as physiotherapy tutorials, clinicians can augment traditional treatment pathways, reducing wait times and enabling early intervention. Furthermore, integrating platforms like YouTube into the healthcare ecosystem can enhance access to care while streamlining the patient journey.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*nl4ti5FfwU_E72CScmIt1Q.png" /><figcaption>HealthTechX 2024: Drs Shubs &amp; Virani speaking on the role of technology in bridging efficiency and access in healthcare.</figcaption></figure><p>The session underscored the need for a strategic approach to content creation, particularly within the constraints of overstretched healthcare systems. For instance, the NHS YouTube channel refrains from creating certain types of service content to avoid exacerbating existing resource burdens. Instead, the focus is on providing valuable information that complements existing services without overwhelming the system.<br>Notably, Drs. Virani and Upadhyay went beyond the efficacy versus access debate, recognizing the intrinsic value of investing in patient education and empowerment. While return on investment is often quantified in financial terms, it extends beyond monetary gains. Saving clinician time, for instance, enables deeper patient engagement and continuity of care, ultimately leading to better health outcomes.</p><p>Overall, the discussion highlighted the potential of healthtech platforms to reconcile the efficacy and access axes in healthcare delivery. By harnessing technology to disseminate high-quality information, healthcare systems can empower patients to make informed decisions while alleviating strain on resources. Moreover, embracing a holistic approach to value creation acknowledges the multifaceted benefits of investing in patient-centred care, paving the way for more sustainable and impactful healthcare solutions.</p><p><a href="https://impactx2050.com/healthtechx/pre-reg-2025"><strong><em>Pre-register here</em></strong></a><em> </em><strong><em>for a 50% discount on 2025 HealthTechX Summit tickets.</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6cdc0671e4ff" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/balancing-efficacy-and-access-in-healthtech-6cdc0671e4ff">Balancing Efficacy and Access in HealthTech</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Beyond the Hype — AI’s Place in Healthcare]]></title>
            <link>https://medium.com/healthtechx360/beyond-the-hype-ais-place-in-healthcare-f72fd138e447?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/f72fd138e447</guid>
            <category><![CDATA[ai-in-healthcare]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[ai-hype]]></category>
            <category><![CDATA[future-of-healthcare]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Tue, 19 Mar 2024 09:28:24 GMT</pubDate>
            <atom:updated>2024-03-19T09:28:24.255Z</atom:updated>
            <content:encoded><![CDATA[<h3>Beyond the Hype — AI’s Place in Healthcare</h3><h4>A panel of experts at the HealthTechX Summit 2024 discuss the reality of AI’s early promise in healthcare and explore its real-world hurdles and long-term potential.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*lKxOqNxRBQt3QxJ1cQEnAQ.jpeg" /><figcaption>From left: Paul Wicks, VP of Neuroscience at Sano Genetics as Moderator; Pearse Keane, Professor of Artificial Medical Intelligence at UCL; Dr Hugh Harvey, Managing Director at Hardian Health &amp; Dr Indra Joshi, Director at Palantir Technologies discussing AI in healthcare at the HealthTechX Summit 2024.</figcaption></figure><p>During a panel discussion at the HealthTechX Summit 2024, a group of experts came together to discuss the current deployments and future potential of artificial intelligence (AI) in healthcare. The session, moderated by Paul Wicks, featured Hugh Harvey, Managing Director at Hardian Health, Pearse Keane, Professor of Artificial Medical Intelligence at UCL, and Indra Joshi, Director of Health, Research &amp; AI at Palantir Technologies.</p><blockquote>AI in healthcare is past the peak of inflated expectations.</blockquote><p><strong>AI in early stages, hype cycle plateauing:</strong></p><p>Professor Keane, a practicing clinician at Moorfield Eye Hospital, grounded the discussion by highlighting the nascent stage of AI in healthcare. He cited a recent study from Stanford University that showed, despite over 500 FDA-cleared AI devices in the US, only two have been adopted by more than ten healthcare providers. Hugh Harvey agreed that this aligns with the Gartner Hype Cycle, which suggests AI in healthcare is past the peak of inflated expectations and entering the “trough of disillusionment.”</p><p><strong>Challenges and considerations:</strong></p><p>The panel acknowledged several challenges hindering widespread AI adoption. Dr. Harvey emphasized the highly regulated nature of healthcare, where patient safety is paramount. He expressed concerns about the potential cost increases associated with AI, including the initial investment, ongoing maintenance, and the additional costs arising from increased detection and treatment needs. He further stressed the importance of demonstrating long-term societal benefits to justify the investment.</p><p><strong>Liability and fragmented systems:</strong></p><p>The discussion also touched upon the complexities of liability in the UK healthcare system, with concerns regarding financial investments and potential legal ramifications. Dr. Joshi of Palantir Technologies highlighted the fragmented nature of the UK’s National Health Service (NHS), contrasting it with the large portfolio deployments seen in the US.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*IBcl4MDf-PZxBT1E1PAg2w.png" /><figcaption>HealthTechX 2024: Panellists speaking on AI’s place in healthcare.</figcaption></figure><p><strong>Trust and regulation:</strong></p><p>The panel addressed the crucial role of trust in AI implementation. While regulators act as safeguards against potential pitfalls, they also face the challenge of keeping pace with the rapid advancements in AI technology. The NHS’s limited software team capacity (8 people for 1,000 products) further underscores the complexities involved. Transparency and clear communication with patients were identified as key factors in building trust.</p><blockquote>Forcing clinicians to adopt inefficient AI systems can lead to workarounds and hinder trust.</blockquote><p><strong>Ensuring equitable care and avoiding pitfalls:</strong></p><p>The panellists emphasized the importance of safeguarding against potential biases and ensuring equitable access to AI-powered healthcare. Forcing clinicians to adopt inefficient AI systems can lead to workarounds and hinder trust. Robust, reliable, and fair systems are crucial for successful implementation.</p><p><strong>Data privacy and the path from idea to implementation:</strong></p><p>Privacy concerns surrounding patient data engagement were acknowledged, highlighting the need for transparency and clear communication. Professor Keane pointed out the vast amount of data required to train AI systems, mentioning the ongoing collaboration between the NHS and DeepMind.</p><p><strong>Sustainable business models:</strong></p><p>The session concluded with a focus on exploring sustainable business models for AI in healthcare. Utilizing anonymized retrospective data for the benefit of the NHS was identified as a potential approach.</p><p>Overall, the panel session offered a comprehensive and realistic overview of the current state and future prospects of AI in healthcare. While the technology holds immense potential, significant challenges remain, including navigating the regulatory landscape, ensuring equitable access, and building trust with all stakeholders.</p><p><a href="https://impactx2050.com/healthtechx/pre-reg-2025"><strong><em>Pre-register here</em></strong></a><em> </em><strong><em>for a 50% discount on 2025 HealthTechX Summit tickets.</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f72fd138e447" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/beyond-the-hype-ais-place-in-healthcare-f72fd138e447">Beyond the Hype — AI’s Place in Healthcare</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Exploring Tech-Driven Approaches to Mental Health]]></title>
            <link>https://medium.com/healthtechx360/exploring-tech-driven-approaches-to-mental-health-be9d32a3cd1c?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/be9d32a3cd1c</guid>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[mental-health]]></category>
            <category><![CDATA[future-of-healthcare]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Wed, 13 Mar 2024 15:39:07 GMT</pubDate>
            <atom:updated>2024-03-13T15:39:07.752Z</atom:updated>
            <content:encoded><![CDATA[<h4>At the HealthTechX Summit 2024, panellists discussed the urgency of the mental health crisis and the need for innovative approaches to address it.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*JBHxQLgCYBUN2QNZhS8Prg.jpeg" /><figcaption>From left: Inga Deakin, Principal at Molten Ventures as Moderator; Nick Taylor, Co-Founder &amp; CEO at Unmind; Andrew Welchman, EVP for Impact and Corporate Development at ieso &amp; Heather Cook, Chair of the Advisory Board at Wellmind Health discussing Mental Health and Prevention at the HealthTechX Summit 2024.</figcaption></figure><p>In a world where mental health issues are on the rise, finding effective solutions has become more crucial than ever. Recently, at the HealthTechX Summit, industry experts gathered to discuss the challenges and opportunities surrounding mental health innovation and prevention. Moderated by Inga Deakin of Molten Ventures, the panel delved into various aspects, from leveraging technology to addressing regulatory hurdles and fostering meaningful partnerships.</p><blockquote>“Nothing about solving our mental health crisis will be simple.”</blockquote><p>The complexities of tackling mental health issues in the modern era set the tone for the discussion. One of the central themes revolved around the role of technology, particularly AI, in addressing mental health challenges. Nick Taylor of Unmind highlighted the potential of AI in democratizing access to mental health care and intervening at the right time. He emphasized the importance of leveraging technology to provide support and early intervention, especially in environments like the workplace where mental health issues often go unnoticed.</p><p>Andrew Welchman from ieso echoed this sentiment, stressing the need for innovation to scale up mental health solutions. He highlighted the significance of leveraging data-driven approaches to provide personalized care at scale, noting that traditional methods have often fallen short in reaching those in need.</p><p>However, the panel also acknowledged the inherent challenges in adopting new technologies, particularly in the realm of mental health. Heather Cook of Wellmind Health asserted the importance of partnerships in navigating these challenges, underscoring the need for collaboration across stakeholders to bring effective solutions to market and reach those who can benefit the most.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*pnKuWvhRv8iec-ol23om-w.png" /><figcaption>HealthTechX 2024: Panellists speaking on Mental Health &amp; Prevention</figcaption></figure><p>The discussion also shed light on the regulatory landscape and the need for agile regulation to keep pace with technological advancements. Panellists emphasized the importance of ensuring that regulations facilitate innovation rather than stifling it, as outdated regulations could drive individuals towards unregulated solutions.</p><p>Throughout the discussion, there was a consensus on the urgency of the mental health crisis and the need for innovative approaches to address it. From leveraging AI for early intervention to fostering partnerships and navigating regulatory challenges, the panel provided valuable insights into the multifaceted nature of mental health innovation.</p><p>As we navigate the complexities of the mental health landscape, it’s clear that collaboration, innovation, and a patient-centric approach will be key to driving meaningful change. While the road ahead may be challenging, the collective commitment of stakeholders to address this pressing issue offers hope for a brighter future.</p><p><a href="https://impactx2050.com/healthtechx/pre-reg-2025"><strong><em>Pre-register here</em></strong></a><em> </em><strong><em>for a 50% discount on 2025 HealthTechX Summit tickets.</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=be9d32a3cd1c" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/exploring-tech-driven-approaches-to-mental-health-be9d32a3cd1c">Exploring Tech-Driven Approaches to Mental Health</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Empowering Women Through Hormonal Health: Dame Jessica Ennis-Hill at the HealthTechX Summit 2024]]></title>
            <link>https://medium.com/healthtechx360/empowering-women-through-hormonal-health-dame-jessica-ennis-hill-at-the-healthtechx-summit-2024-4bc1d46d5516?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/4bc1d46d5516</guid>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[resilience]]></category>
            <category><![CDATA[femtech]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Wed, 06 Mar 2024 09:16:59 GMT</pubDate>
            <atom:updated>2024-03-06T09:19:06.313Z</atom:updated>
            <content:encoded><![CDATA[<h4>From Olympic glory to FemTech entrepreneurship, Dame Jessica Ennis-Hill shares her insights and experiences with a powerful message of determination, resilience, and the transformative power of health technology.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ym_zdQZHbSnquzwjHP9XsA.jpeg" /><figcaption>Dame Jessica Ennis-Hill took centre stage at the 2024 HealthTechX Summit.</figcaption></figure><p>At the recent HealthTechX Summit, Dame Jessica Ennis-Hill, Olympic Champion and founder of the women’s hormonal health platform Jennis, took centre stage to share her transformative journey from elite athlete to FemTech founder. Combining her personal experiences with her passion for sport and learnings of hormonal health, Jessica delved into the motivations behind her venture and the challenges she seeks to address.</p><p>Jessica’s journey with Jennis began with a desire to continue competing after becoming a mother. Drawing from her own experiences during pregnancy and postnatal recovery, she recognized the lack of support for women to understand their bodies’ hormonal changes. This realization fuelled her mission to create a platform that empowers women to gain insights into their hormonal health beyond just fertility.</p><p>Sharing her personal reflections, the gold medallist emphasized that her passion for sport and the transformative journey with her son played pivotal roles in sparking her interest in the HealthTech arena. As an athlete, she was intimately familiar with her body, but motherhood introduced her to a new dimension of understanding and appreciating its complexities.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Zfj7W30ucqcNO7qkhfncnw.jpeg" /><figcaption>Dame Jessica Ennis-Hill emphasized the need to educate women about all hormonal changes they may experience throughout their lives.</figcaption></figure><p>Using data-driven approaches, Jennis aims to bridge the gap between women’s awareness of their bodies and a deeper understanding of their hormonal cycles. Jessica noted the challenges of gathering data in this area but emphasized the importance of listening to women’s experiences and feedback to tailor the platform effectively.</p><p>In terms of the broader significance of hormonal health beyond fertility, Jessica underlined the value of educating women about the various hormonal changes they experience throughout their lives, including the impact of exercise and lifestyle choices. Fundamentally, Jennis aims to empower women with the knowledge and tools to proactively manage their hormonal health.</p><p>Reflecting on her transition from elite athlete to business owner, the Olympic champion shared lessons learned from her sporting career, including the importance of teamwork and resilience. She emphasized the value of pushing oneself out of comfort zones and embracing failure as essential elements of growth, both in sport and in business.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*jZLEr2lQJ3Zo3NFUUD-8jA.jpeg" /><figcaption>Transitioning from an elite athlete to a business leader, Jessica brought valuable lessons from the world of sports to her entrepreneurial journey.</figcaption></figure><p>Jessica also highlighted the neglect of women’s health in elite sports and the broader healthcare landscape. With less research and funding dedicated to women’s health, she is committed to driving change and raising awareness about the unique needs of women. Looking ahead, Jessica and her team are focused on reaching as many women as possible, particularly in the direct-to-consumer space. They aim to make the platform accessible and personalized, catering to the needs of everyday women while also bringing attention to women’s health at the elite level.</p><p>In essence, Dame Jessica’s journey epitomizes the intersection of passion, perseverance, and purpose. Through Jennis, she is is driving meaningful impact in the realm of healthtech, paving the way for a future where women can truly understand, embrace, and optimize their hormonal health.</p><p><a href="https://impactx2050.com/healthtechx/pre-reg-2025"><strong><em>Pre-register here</em></strong></a><em> </em><strong><em>for your 2025 HealthTechX Summit ticket.</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4bc1d46d5516" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/empowering-women-through-hormonal-health-dame-jessica-ennis-hill-at-the-healthtechx-summit-2024-4bc1d46d5516">Empowering Women Through Hormonal Health: Dame Jessica Ennis-Hill at the HealthTechX Summit 2024</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[HealthTechX Award Winners 2024 — Lindus Health & Evergreen Life take the honours.]]></title>
            <link>https://medium.com/healthtechx360/healthtechx-award-winners-2024-lindus-health-evergreen-life-take-the-honours-840771500d3a?source=rss----51fbe69cfce1---4</link>
            <guid isPermaLink="false">https://medium.com/p/840771500d3a</guid>
            <category><![CDATA[healthtechx]]></category>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[growth]]></category>
            <category><![CDATA[awards]]></category>
            <dc:creator><![CDATA[HealthTechX]]></dc:creator>
            <pubDate>Tue, 05 Mar 2024 08:59:45 GMT</pubDate>
            <atom:updated>2024-03-05T11:10:23.153Z</atom:updated>
            <content:encoded><![CDATA[<h3>HealthTechX Award Winners 2024 — Lindus Health &amp; Evergreen Life take the honours.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*AZ9QKt6fb0Q8QzY_7sIzGw.png" /></figure><p>The winners of IBIS Capital’s 2024 HealthTechX Awards were revealed on stage at the <a href="https://impactx2050.com/healthtechx">HealthTechX Summit</a> on 28th February. Celebrating innovation, impact and growth, the awards recognise companies that are using technology to advance healthcare and support patients, providers, payers, and pharma in delivering more efficient care for better outcomes.</p><p>The two winners were selected from a pool of finalists across two categories based on the companies’ growth stage. Read on to find out more about the winners and finalists…</p><h3>2024 Innovator Award Winner</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/900/1*9s-aNyH071lup-naauXxCQ.png" /><figcaption><a href="https://www.lindushealth.com/">www.lindushealth.com</a></figcaption></figure><p>Lindus Health is a next-generation CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a unique software platform, access to 20 million Electronic Health Records and a world-class clinical operation team. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 80 sponsors run entire clinical studies up to 3x faster than typical CROs.</p><p>Our IBIS Capital judging panel commented, “<em>When we think about innovations in the drug discovery and development pipeline, so much attention has gone to AI-based drug discovery solutions. The reality is that the costliest and longest phase of bringing new therapeutics to patients is actually the clinical development process. Lindus Health is a next-generation contract research organisation which has helped over 80 clients run entire clinical studies up to three times faster than traditional providers. These trials have been run across a wide range of conditions including type 2 diabetes and COPD, allowing patients to benefit from new treatments more quickly.</em>”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*2WfeZ8wuo2UM2lkSQhDO0g.jpeg" /><figcaption>Meri Beckwith, Co-Founder at Lindus Health (right) accepting the 2024 HealthTechX Innovator Award.</figcaption></figure><p>“<em>Everyone agrees that the clinical research space is in need of change, yet clinical research sponsors can be reluctant to try something new</em>,” said Co-Founder, Meri Beckwith. “<em>That’s why we’re so thrilled to win the HealthTechX Innovator award, as it helps shine a light on the impact we’ve been able to have in conducting faster, more reliable clinical trials for groundbreaking treatments. It’s nice to have our hard work recognised alongside some other fantastic winners and nominees this year. Thank you to the judges and the HealthTechX team for making it happen!</em>”</p><h3>2024 Growth Award Winner</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Hi7p7cQydreIjbcd-hw0Ew.png" /><figcaption><a href="https://www.evergreen-life.co.uk/">www.evergreen-life.co.uk</a></figcaption></figure><p>Evergreen Life is dedicated to improving the health and happiness of the population, and reducing pressure on our healthcare systems, by empowering people to take control of their own health. Central to our focus on ‘People Powered Health’ is how we enable people to curate their own personal health record and share this information currently held by different health organisations through a digital app-based solution.</p><p>“<em>This company is solving real problems within the UK healthcare system,” </em>the IBIS Capital judging panel commented.<em> </em>“<em>Of the long list of problems that impact the NHS, waiting lists come at the top of the list. Evergreen Life’s central belief is that the patient should be at the centre of all healthcare decisions, and that this shift can improve the system’s efficiencies. By combining electronic health records, telemedicine, precision diagnostics and monitoring, Evergreen Life empowers patients to make informed decisions and eases pressure on both primary and secondary care ecosystems in the UK. In one trust, waiting times for referrals were reduced from 33 weeks to 2 days — showing true impact in action</em>.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MuC4nYWNzpmFoP0xRBo-wg.jpeg" /><figcaption>Stephen Critchlow, Founder &amp; CEO at Evergreen Life (right) accepting the 2024 HealthTechX Growth Award.</figcaption></figure><p>“<em>I know our team at Evergreen work so hard, often in difficult circumstances, to mean people are healthier and happier</em>,” said Founder &amp; CEO, Stephen Critchlow. “<em>This award will mean so much to them to know that we are growing and seen by others to be in a position to keep growing. We would like to see the whole health system globally benefit from what we are doing</em>.”</p><h4>We would like to congratulate all of our 2024 shortlisted finalists.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*QcKpJpFLrTfnqZr_Iib-jA.png" /><figcaption>Celebrating companies with less than $10M USD revenue</figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*GeEVwc-R-TYFf_hssVNi7g.png" /><figcaption>Celebrating companies with more than $10M USD revenue</figcaption></figure><p><em>Find out more about the HealthTechX Awards </em><a href="https://impactx2050.com/healthtechx/awards-finalists"><em>here</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=840771500d3a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthtechx360/healthtechx-award-winners-2024-lindus-health-evergreen-life-take-the-honours-840771500d3a">HealthTechX Award Winners 2024 — Lindus Health &amp; Evergreen Life take the honours.</a> was originally published in <a href="https://medium.com/healthtechx360">HealthTechX360</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>